Sfoglia per Autore
IL-4 gene delivery induces clinical and functional recovery in mice affected MOG35-55-induced EAE by recruiting CD4+CD25+ regulatory T cells to the CNS
2004-01-01 Butti, E; Bergami, A; Brambilla, E; Del Carro, U; Amadio, S; Comi, G; Pluchino, S; Martino, G; Mavilio, E; Furlan, R
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis
2004-01-01 Furlan, R; Kurne, A; Bergami, A; Brambilla, E; Maucci, R; Gasparini, L; Butti, E; Ongini, E; Comi, G; Martino, G
Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies
2004-01-01 Pluchino, S; Furlan, R; Martino, Gianvito
Similar low frequency of anit-MOG IgG and IgM in MS patients and healthy subjects
2004-01-01 Lampasona, V; Franciotta, D; Furlan, R; Zanaboni, S; Fazio, R; Bonifacio, E; Comi, G; Martino, G
alpha-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis
2004-01-01 Morini, M; Roccatagliata, L; Dell'Eva, R; Pedemonte, E; Furlan, R; Minghelli, S; Giunti, D; Pfeffer, U; Marchese, M; Noonan, D; Mancardi, G; Albini, A; Uccelli, A
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis
2004-01-01 Butti, E; Recchia, A; Bergami, A; Stornaiuolo, A; Brambilla, E; Furlan, R; Martino, G; Mavilio, F
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury
2004-01-01 Perego, C; Echart, C; Rossi, E; Butti, E; Furlan, R; Veglianese, P; Martino, G; De Simoni, Mg
Intrathecal administration of an IL-4-expressing helper dependent adenoviral vector is not immunogenic or toxic in the presence of pre-existing anti-adenoviral immunity in non-human primates
2005-01-01 Butti, E; Bergami, A; Franciotta, D; Brambilla, E; Cattalini, A; Coville, M; Moullier, P; Lachapelle, F; Mavilio, E; Martino, G; Furlan, R
Gene therapy approaches for autoimmune diseases of central nervous system and other tissues
2005-01-01 Furlan, R; Butti, E; Pluchino, S; Martino, Gianvito
Gene and stem cell therapy for autoimmune demyelination
2005-01-01 Pluchino, ; Bacigaluppi, M; Bucello, S; Butti, E; Deleidi, M; Zanotti, L; Martino, G; Furlan, R
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
2005-01-01 Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, Giancarlo; Constantin, G; Martino, Gianvito
Immunological patterns identifying disease course and evolution in multiple sclerosis patients
2005-01-01 Furlan, R; Rovaris, M; Boneschi, Fm; Khademi, M; Bergami, A; Gironi, M; Deleidi, M; Agosta, F; Franciotta, D; Scarpini, E; Uccelli, A; Zaffaroni, M; Kurne, A; Comi, G; Olsson, T; Filippi, M; Martino, G
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS
2005-01-01 Butti, E; Porcheri, C; Bergami, A; Brambilla, E; Cattalini, A; Recchia, A; Stornauiolo, A; Mavilio, E; Martino, G; Furlan, R
JNK inhibition as potential treatment for multiple sclerosis
2006-01-01 Ferrandi, C; Brichory, F; Muzio, V; Martini, P; Furlan, R; Martino, G; Tavano, P; Magnone, Mc; Comi, G; Greco, B; Gotteland, Jp; Wells, T; Zaratin, Pf
The ependymal route for central nervous system gene therapy
2006-01-01 Butti, E; Martino, Gianvito; Furlan, R.
Common transcriptional signature in the clinical forms of multiple sclerosis: the role of downregulation of apoptotic genes
2006-01-01 Brini, E; Martini, P; Barbie, V; Furlan, R; Ferrandi, C; Comi, G; Wells, T; Mariani, M; Martino, G; Zaratin, Pf
Secondary progressive multiple sclerosis: current knowledge and future challenges
2006-01-01 Rovaris, M; Confavreux, C; Furlan, R; Kappos, L; Comi, Giancarlo; Filippi, Massimo
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
2007-01-01 Furlan, R; Bergami, A; Brambilla, E; Butti, E; De Simoni, Mg; Campagnoli, M; Marconi, P; Martino, Gianvito; Comi, Giancarlo
Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia
2007-01-01 Muzio, L; Martino, Gianvito; Furlan, R.
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis
2007-01-01 Centonze, D; Bari, M; Rossi, S; Prosperetti, C; Furlan, R; Fezza, F; De Chiara, V; Battistini, L; Bernardi, G; Bernardini, S; Martino, Gianvito; Maccarrone, M.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
IL-4 gene delivery induces clinical and functional recovery in mice affected MOG35-55-induced EAE by recruiting CD4+CD25+ regulatory T cells to the CNS | 1-gen-2004 | Butti, E; Bergami, A; Brambilla, E; Del Carro, U; Amadio, S; Comi, G; Pluchino, S; Martino, G; Mavilio, E; Furlan, R | |
A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis | 1-gen-2004 | Furlan, R; Kurne, A; Bergami, A; Brambilla, E; Maucci, R; Gasparini, L; Butti, E; Ongini, E; Comi, G; Martino, G | |
Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies | 1-gen-2004 | Pluchino, S; Furlan, R; Martino, Gianvito | |
Similar low frequency of anit-MOG IgG and IgM in MS patients and healthy subjects | 1-gen-2004 | Lampasona, V; Franciotta, D; Furlan, R; Zanaboni, S; Fazio, R; Bonifacio, E; Comi, G; Martino, G | |
alpha-Lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis | 1-gen-2004 | Morini, M; Roccatagliata, L; Dell'Eva, R; Pedemonte, E; Furlan, R; Minghelli, S; Giunti, D; Pfeffer, U; Marchese, M; Noonan, D; Mancardi, G; Albini, A; Uccelli, A | |
Clinical and functional recovery from experimental autoimmune encephalomyelitis by intracisternal delivery of IL4 from a helper-dependent adenoviral vector. A pre-clinical model of gene therapy of multiple sclerosis | 1-gen-2004 | Butti, E; Recchia, A; Bergami, A; Stornaiuolo, A; Brambilla, E; Furlan, R; Martino, G; Mavilio, F | |
Adenovirus-mediated IL-4 transfer is protective in ischemia/reperfusion brain injury | 1-gen-2004 | Perego, C; Echart, C; Rossi, E; Butti, E; Furlan, R; Veglianese, P; Martino, G; De Simoni, Mg | |
Intrathecal administration of an IL-4-expressing helper dependent adenoviral vector is not immunogenic or toxic in the presence of pre-existing anti-adenoviral immunity in non-human primates | 1-gen-2005 | Butti, E; Bergami, A; Franciotta, D; Brambilla, E; Cattalini, A; Coville, M; Moullier, P; Lachapelle, F; Mavilio, E; Martino, G; Furlan, R | |
Gene therapy approaches for autoimmune diseases of central nervous system and other tissues | 1-gen-2005 | Furlan, R; Butti, E; Pluchino, S; Martino, Gianvito | |
Gene and stem cell therapy for autoimmune demyelination | 1-gen-2005 | Pluchino, ; Bacigaluppi, M; Bucello, S; Butti, E; Deleidi, M; Zanotti, L; Martino, G; Furlan, R | |
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism | 1-gen-2005 | Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, Giancarlo; Constantin, G; Martino, Gianvito | |
Immunological patterns identifying disease course and evolution in multiple sclerosis patients | 1-gen-2005 | Furlan, R; Rovaris, M; Boneschi, Fm; Khademi, M; Bergami, A; Gironi, M; Deleidi, M; Agosta, F; Franciotta, D; Scarpini, E; Uccelli, A; Zaffaroni, M; Kurne, A; Comi, G; Olsson, T; Filippi, M; Martino, G | |
A helper dependent adenovirus efficiently delivers bioactive FGF-II to the CNS | 1-gen-2005 | Butti, E; Porcheri, C; Bergami, A; Brambilla, E; Cattalini, A; Recchia, A; Stornauiolo, A; Mavilio, E; Martino, G; Furlan, R | |
JNK inhibition as potential treatment for multiple sclerosis | 1-gen-2006 | Ferrandi, C; Brichory, F; Muzio, V; Martini, P; Furlan, R; Martino, G; Tavano, P; Magnone, Mc; Comi, G; Greco, B; Gotteland, Jp; Wells, T; Zaratin, Pf | |
The ependymal route for central nervous system gene therapy | 1-gen-2006 | Butti, E; Martino, Gianvito; Furlan, R. | |
Common transcriptional signature in the clinical forms of multiple sclerosis: the role of downregulation of apoptotic genes | 1-gen-2006 | Brini, E; Martini, P; Barbie, V; Furlan, R; Ferrandi, C; Comi, G; Wells, T; Mariani, M; Martino, G; Zaratin, Pf | |
Secondary progressive multiple sclerosis: current knowledge and future challenges | 1-gen-2006 | Rovaris, M; Confavreux, C; Furlan, R; Kappos, L; Comi, Giancarlo; Filippi, Massimo | |
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice | 1-gen-2007 | Furlan, R; Bergami, A; Brambilla, E; Butti, E; De Simoni, Mg; Campagnoli, M; Marconi, P; Martino, Gianvito; Comi, Giancarlo | |
Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia | 1-gen-2007 | Muzio, L; Martino, Gianvito; Furlan, R. | |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis | 1-gen-2007 | Centonze, D; Bari, M; Rossi, S; Prosperetti, C; Furlan, R; Fezza, F; De Chiara, V; Battistini, L; Bernardi, G; Bernardini, S; Martino, Gianvito; Maccarrone, M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile